CompletedPHASE2, PHASE3NCT02342171

Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea

Studying Ebola hemorrhagic fever

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Institute of Tropical Medicine, Belgium
Principal Investigator: Johan van Griensven, MD
ITM
Intervention: Convalescent Plasma(other)
Enrollment: 606 enrolled
Eligibility: All sexes
Timeline: 2015 – 2015

Study locations (1)

Ebola Treatment Center, Donka, Guinea

Collaborators

National Blood Transfusion Centre (NBTC), Conakry, Guinea · Gamal Abdel Nasser University of Conakry · National Center for Training and Research of Maferinyah, Guinea · Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo · University of Oxford · University of Liverpool · London School of Hygiene and Tropical Medicine · Aix Marseille Université · UBIVE, Institut Pasteur, Paris, France · Institut National de la Santé Et de la Recherche Médicale, France · Etablissement Français du Sang · Belgian Red Cross · Institut Pasteur, Dakar, Sénégal · Médecins Sans Frontières, Belgium · World Health Organization · International Severe Acute Respiratory and Emerging Infection Consortium

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02342171 on ClinicalTrials.gov

Other trials for Ebola hemorrhagic fever

Additional recruiting or active studies for the same condition.

See all trials for Ebola hemorrhagic fever →

← Back to all trials